EligibleTrials

V+PSF-M for Tobacco Cessation in HIV Care in India

Recruiting · NCT05786547 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Colorado, Denver

View the official record on ClinicalTrials.gov →
HIV

Interventions studied

Positively Smoke Free Mobile (PSF-M)Standard CareVarenicline

What this trial is about

The goal of this research study is to test an intervention to help quit tobacco use in participants with Human Immunodeficiency Virus (HIV). The study interventions used in this research study are: * Positively Smoke Free - Mobile (PSF-M) (mobile behavioral program) * Varenicline (or Chantix, apovarenicline, Champix or Nocrav)

Who can take part

Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

2 locations listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.